ESSA Pharma | 8-K:ESSA Pharma提供截至2024年3月31日的第二財季公司最新情況並報告財務業績
ESSA Pharma | 10-Q:季度報表
ESSA Pharma | 4:持股變動聲明-高管 Virsik Peter
ESSA Pharma | 4:持股變動聲明-董事 Glickman Richard M
ESSA Pharma | 4:持股變動聲明-高管 Virsik Peter
ESSA Pharma | S-8:員工福利計劃證券登記
ESSA Pharma | 144:擬議出售證券
ESSA Pharma | 4:持股變動聲明-董事 ZWEIFACH SANFORD S
ESSA Pharma | 4:持股變動聲明-董事 Thorell Marella
ESSA Pharma | 4:持股變動聲明-董事 Sollis Gary
ESSA Pharma | 4:持股變動聲明-董事 Requadt Scott
ESSA Pharma | 4:持股變動聲明-董事 Merendino Lauren
ESSA Pharma | 4:持股變動聲明-董事 Martin John Alexander
ESSA Pharma | 4:持股變動聲明-董事 Kantoff Philip W.
ESSA Pharma | 4:持股變動聲明-董事 Glickman Richard M
ESSA Pharma | 4:持股變動聲明-董事 BERGER FRANKLIN M
ESSA Pharma | 4:持股變動聲明-高管 Wood David S.
ESSA Pharma | 4:持股變動聲明-高管 Virsik Peter
ESSA Pharma | 4:持股變動聲明-高管 Parkinson David Ross
ESSA Pharma | 4:持股變動聲明-高管 Cesano Alessandra
暫無數據